Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Journal
The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617
Informations de publication
Date de publication:
06 09 2022
06 09 2022
Historique:
entrez:
6
9
2022
pubmed:
7
9
2022
medline:
9
9
2022
Statut:
ppublish
Résumé
Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. To review AMR in Kuwait and initiatives underway addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Kuwait and to improve patient outcomes. National initiatives to address AMR, antibiotic use and prescribing, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from a clinician in Kuwait were sought to contextualize this information. In Kuwait there have been some initiatives addressing AMR such as annual campaigns for proper use of antibiotics. Antibiotic use is high but there appears to be a low understanding in the general public about their appropriate use. However, there is legislation in place prohibiting over-the-counter purchase of antibiotics. Only international guidelines for CA-RTIs are used. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Kuwait, could make management guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical patient outcomes.
Sections du résumé
BACKGROUND
Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action.
OBJECTIVES
To review AMR in Kuwait and initiatives underway addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Kuwait and to improve patient outcomes.
METHODS
National initiatives to address AMR, antibiotic use and prescribing, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from a clinician in Kuwait were sought to contextualize this information.
CONCLUSIONS
In Kuwait there have been some initiatives addressing AMR such as annual campaigns for proper use of antibiotics. Antibiotic use is high but there appears to be a low understanding in the general public about their appropriate use. However, there is legislation in place prohibiting over-the-counter purchase of antibiotics. Only international guidelines for CA-RTIs are used. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Kuwait, could make management guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical patient outcomes.
Identifiants
pubmed: 36065725
pii: 6692264
doi: 10.1093/jac/dkac220
pmc: PMC9445856
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
i77-i83Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Références
J Antimicrob Chemother. 2022 Sep 6;77(Supplement_1):i2-i9
pubmed: 36065724
Global Health. 2006 Apr 07;2:6
pubmed: 16603071
Glob Health Med. 2019 Dec 31;1(2):61-64
pubmed: 33330756
J Antimicrob Chemother. 2002 Jan;49(1):31-40
pubmed: 11751764
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
East Mediterr Health J. 2017 Aug 20;23(6):430-440
pubmed: 28836656
J Infect Public Health. 2019 Mar - Apr;12(2):159-166
pubmed: 30245158
Med Princ Pract. 2010;19(5):339-43
pubmed: 20639654
Clin Microbiol Infect. 2004 Apr;10 Suppl 2:18-27
pubmed: 14759230
J Antimicrob Chemother. 2016 May;71 Suppl 1:i85-91
pubmed: 27048585
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
PLoS One. 2015 Feb 12;10(2):e0117910
pubmed: 25675405
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
Euro Surveill. 2015 May 28;20(21):
pubmed: 26062562
Clin Microbiol Rev. 2007 Jul;20(3):391-408, table of contents
pubmed: 17630331
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Clin Infect Dis. 2012 Apr;54(8):e72-e112
pubmed: 22438350
Thorax. 2011 Oct;66 Suppl 2:ii1-23
pubmed: 21903691
Clin Microbiol Infect. 2019 Jul;25(7):910-911
pubmed: 30910717
Pediatrics. 2013 Mar;131(3):e964-99
pubmed: 23439909
Thorax. 2009 Oct;64 Suppl 3:iii1-55
pubmed: 19783532
Clin Infect Dis. 2011 Oct;53(7):e25-76
pubmed: 21880587
Front Microbiol. 2011 Nov 24;2:230
pubmed: 22164154
J Infect Public Health. 2010;3(2):60-6
pubmed: 20701893
J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i60-i75
pubmed: 32337592